JP2019147836A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019147836A5 JP2019147836A5 JP2019097670A JP2019097670A JP2019147836A5 JP 2019147836 A5 JP2019147836 A5 JP 2019147836A5 JP 2019097670 A JP2019097670 A JP 2019097670A JP 2019097670 A JP2019097670 A JP 2019097670A JP 2019147836 A5 JP2019147836 A5 JP 2019147836A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- nutritional supplement
- composition
- fatty acids
- lysolipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361822095P | 2013-05-10 | 2013-05-10 | |
| US61/822,095 | 2013-05-10 | ||
| JP2016513125A JP6533519B2 (ja) | 2013-05-10 | 2014-05-09 | Ｒａｓがんにおける脂質捕捉 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513125A Division JP6533519B2 (ja) | 2013-05-10 | 2014-05-09 | Ｒａｓがんにおける脂質捕捉 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019147836A JP2019147836A (ja) | 2019-09-05 |
| JP2019147836A5 true JP2019147836A5 (enExample) | 2020-01-16 |
| JP6970709B2 JP6970709B2 (ja) | 2021-11-24 |
Family
ID=51867773
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513125A Active JP6533519B2 (ja) | 2013-05-10 | 2014-05-09 | Ｒａｓがんにおける脂質捕捉 |
| JP2019097670A Active JP6970709B2 (ja) | 2013-05-10 | 2019-05-24 | Ｒａｓがんにおける脂質捕捉 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016513125A Active JP6533519B2 (ja) | 2013-05-10 | 2014-05-09 | Ｒａｓがんにおける脂質捕捉 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10130600B2 (enExample) |
| EP (1) | EP2993980B1 (enExample) |
| JP (2) | JP6533519B2 (enExample) |
| AU (3) | AU2014262450A1 (enExample) |
| CA (2) | CA2912052C (enExample) |
| IL (2) | IL242492B (enExample) |
| WO (1) | WO2014183047A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8338109B2 (en) | 2006-11-02 | 2012-12-25 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| CA2725978A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
| US8669057B2 (en) | 2009-05-07 | 2014-03-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
| US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| US10513737B2 (en) | 2011-12-13 | 2019-12-24 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| ES3015226T3 (en) | 2012-08-16 | 2025-04-30 | Veracyte Sd Inc | Prostate cancer prognosis using biomarkers |
| WO2014186036A1 (en) | 2013-03-14 | 2014-11-20 | Allegro Diagnostics Corp. | Methods for evaluating copd status |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| EP2993980B1 (en) | 2013-05-10 | 2023-11-01 | Memorial Sloan Kettering Cancer Center | Lipid scavenging in ras cancers |
| US11369588B2 (en) | 2014-03-20 | 2022-06-28 | The Trustees Of Princeton University | NADPH production by the 10-formyl-THF pathway, and its use in the diagnosis and treatment of disease |
| US12297505B2 (en) | 2014-07-14 | 2025-05-13 | Veracyte, Inc. | Algorithms for disease diagnostics |
| CN114606309A (zh) | 2014-11-05 | 2022-06-10 | 威拉赛特公司 | 使用机器学习和高维转录数据的诊断系统和方法 |
| US11414708B2 (en) | 2016-08-24 | 2022-08-16 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| AU2018210695B2 (en) | 2017-01-20 | 2024-07-18 | The University Of British Columbia | Molecular subtyping, prognosis, and treatment of bladder cancer |
| WO2018165600A1 (en) | 2017-03-09 | 2018-09-13 | Genomedx Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| US11078542B2 (en) | 2017-05-12 | 2021-08-03 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| AU2018310987A1 (en) | 2017-08-04 | 2020-02-27 | Decipher Biosciences, Inc. | Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07509470A (ja) * | 1992-07-24 | 1995-10-19 | ザ・ジョーンズ・ホプキンス・ユニバーシティ | がんの治療に脂肪酸合成阻害剤を用いる方法 |
| US6156504A (en) | 1996-03-15 | 2000-12-05 | The Penn State Research Foundation | Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
| US6214875B1 (en) * | 1998-04-14 | 2001-04-10 | Zhenhua Yang | Anticancer effects of specific branched-chain fatty acids and related production process |
| CA2519773C (en) | 2003-03-27 | 2014-02-18 | Kengo Akimoto | Lipid-improving agent and composition containing lipid-improving agent |
| US8092839B2 (en) * | 2004-12-13 | 2012-01-10 | Swing Aerobics Licensing, Inc. | Medicament for treatment of cancer and other diseases |
| US8652508B2 (en) * | 2007-05-25 | 2014-02-18 | Children's Medical Center Corporation | Dietary formulations and methods for treatment of inflammation and other disorders |
| US20100129430A1 (en) * | 2008-11-24 | 2010-05-27 | Stavroula Sofou | Liposome drug carriers with ph-sensitivity |
| TWI629992B (zh) | 2011-05-27 | 2018-07-21 | 明治股份有限公司 | 用於預防以及／或者改善癌症引起的非可逆性的代謝紊亂的組合物 |
| RS56394B1 (sr) * | 2011-06-15 | 2017-12-29 | Stable Solutions Llc | Terapeutska primena parenteralnog kril ulja |
| EP2993980B1 (en) | 2013-05-10 | 2023-11-01 | Memorial Sloan Kettering Cancer Center | Lipid scavenging in ras cancers |
-
2014
- 2014-05-09 EP EP14794747.7A patent/EP2993980B1/en active Active
- 2014-05-09 WO PCT/US2014/037514 patent/WO2014183047A1/en not_active Ceased
- 2014-05-09 AU AU2014262450A patent/AU2014262450A1/en not_active Abandoned
- 2014-05-09 JP JP2016513125A patent/JP6533519B2/ja active Active
- 2014-05-09 US US14/890,106 patent/US10130600B2/en active Active
- 2014-05-09 CA CA2912052A patent/CA2912052C/en active Active
- 2014-05-09 CA CA3136947A patent/CA3136947C/en active Active
-
2015
- 2015-11-08 IL IL242492A patent/IL242492B/en active IP Right Grant
-
2018
- 2018-03-14 AU AU2018201800A patent/AU2018201800C1/en active Active
- 2018-10-15 US US16/160,237 patent/US10772862B2/en active Active
-
2019
- 2019-05-24 JP JP2019097670A patent/JP6970709B2/ja active Active
-
2021
- 2021-01-20 AU AU2021200360A patent/AU2021200360A1/en not_active Abandoned
- 2021-04-11 IL IL282229A patent/IL282229B2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11400105B2 (en) | Anti-inflammatory properties of marine lipid compositions | |
| JP2011137015A5 (enExample) | ||
| Jump et al. | Omega-3 fatty acid supplementation and cardiovascular disease: thematic review series: new lipid and lipoprotein targets for the treatment of cardiometabolic diseases | |
| Betancor et al. | Influence of dietary docosahexaenoic acid in combination with other long-chain polyunsaturated fatty acids on expression of biosynthesis genes and phospholipid fatty acid compositions in tissues of post-smolt Atlantic salmon (Salmo salar) | |
| Kaur et al. | Short-term docosapentaenoic acid (22: 5n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentrations in rats | |
| JP2008542280A5 (enExample) | ||
| JP2010162032A5 (enExample) | ||
| PH12016501194A1 (en) | Lipid comprising long chain polyunsaturated fatty acids | |
| CN103609933A (zh) | 一种用于肿瘤患者的肠内营养乳剂 | |
| WO2013153071A3 (en) | A nutritional composition | |
| JP2016521286A5 (enExample) | ||
| WO2008147562A3 (en) | Dietary formulations and methods for treatment of inflammation and other disorders | |
| WO2016040570A3 (en) | Dietary emulsion formulations and methods for using the same | |
| PH12018500036A1 (en) | Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid | |
| Chapkin et al. | Dietary manipulation of macrophage phospholipid classes: selective increase of dihomogammalinolenic acid | |
| WO2014089511A3 (en) | Administering compositions comprising docosapentaenoic acid | |
| PH12019501255A1 (en) | Nutritional composition for improving cell membranes | |
| JP2016501248A5 (enExample) | ||
| WO2011137160A3 (en) | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans | |
| Zuo et al. | Effects of short‐term supplementation with DHA‐enriched phosphatidylcholine and phosphatidylserine on lipid profiles in the brain and liver of n‐3 PUFA‐deficient mice in early life after weaning | |
| Saito et al. | Characteristics of lipid composition differences between cultured and wild ayu (Plecoglossus altivelis) | |
| Schnebelen et al. | Dietary n‐3 and n‐6 PUFA Enhance DHA Incorporation in Retinal Phospholipids Without Affecting PGE1 and PGE2 Levels | |
| HK1201744A1 (en) | Composition for improving neuropsychological test battery score | |
| Wang et al. | The rapid effects of eicosapentaenoic acid (EPA) enriched phospholipids on alleviating exercise fatigue in mice | |
| JP2016086757A5 (enExample) |